mRNA |
NU-7441 |
GDSC1000 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
0.028 |
0.6 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.026 |
0.6 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.015 |
0.6 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.024 |
0.6 |